Auteurs
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Auteurs » - entrée « Luigi Sinigaglia »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Luigi Naldi < Luigi Sinigaglia < Luigia Grazia Fresu  Facettes :

List of bibliographic references indexed by Luigi Sinigaglia

Number of relevant bibliographic references: 4.
Ident.Authors (with country if any)Title
000430 (2020) Marco A. Cimmino [Italie] ; Massimiliano Parodi [Italie] ; Francesca Barbieri [Italie] ; Stefano Bombardieri [Italie] ; Giuseppe Zampogna [Italie] ; Annamaria Iagnocco [Italie] ; Alberto Batticciotto [Italie] ; Luca Maria Sconfienza [Italie] ; Luigi Sinigaglia [Italie] ; Fabrizio De Benedetti [Italie] ; Fabiola Atzeni [Italie] ; Piercarlo Sarzi-Puttini [Italie]Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
000831 (2019) Laura Bazzichi [Italie] ; Francesca Nacci [Italie] ; Luigi Sinigaglia [Italie] ; Laura Bianchino [Italie] ; Roberto Caporali [Italie]Subcutaneous tocilizumab alone or with a csDMARD in rheumatoid arthritis patients: subanalysis of Italian data from a multicenter phase IIIb/IV trial.
000A91 (2019) Serena Colafrancesco [Italie] ; Maria Manara [Italie] ; Alessandra Bortoluzzi ; Teodora Serban [Italie] ; Gerolamo Bianchi [Italie] ; Luca Cantarini [Italie] ; Francesco Ciccia [Italie] ; Lorenzo Dagna [Italie] ; Marcello Govoni ; Carlomaurizio Montecucco [Italie] ; Roberta Priori [Italie] ; Angelo Ravelli [Italie] ; Paolo Sfriso [Italie] ; Luigi Sinigaglia [Italie]Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts
001262 (2018) Luciana Scalone ; Piercarlo Sarzi-Puttini [Italie] ; Luigi Sinigaglia [Italie] ; Carlomaurizio Montecucco [Italie] ; Roberto Giacomelli [Italie] ; Giovanni Lapadula [Italie] ; Ignazio Olivieri [Italie] ; Angela Maria Giardino [Italie] ; Paolo Angelo Cortesi ; Lorenzo Giovanni Mantovani ; Monica Mecchia [Italie]Patients’, physicians’, nurses’, and pharmacists’ preferences on the characteristics of biologic agents used in the treatment of rheumatic diseases

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i -k "Luigi Sinigaglia" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Author.i  \
                -Sk "Luigi Sinigaglia" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Author.i
   |clé=    Luigi Sinigaglia
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021